Novel prolyl oligopeptidase ligands as potential disease-modifying therapies for neurodegenerative diseases
-
Session description:
Chairs: Kim Brøsen and Ulf Simonsen
Novel prolyl oligopeptidase ligands as potential disease-modifying therapies for neurodegenerative diseases
Timo Myöhänen, Finland
Supported by "Basic & Clinical Pharmacology & Toxicology"